MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
Architects: Pulmonology (Drugs, Pharmaceuticals, Biotechnology & Biosimilars)
Galecto Biotech, Inc. (Nasdaq: GLTO)
Attachments
Galecto, Inc. – The leading developer of galectin modulators for the treatment of severe diseases
Parents
2024: Biopharma Layoff Tracker 2024: C4, Affimed, Senti and More Cut Staff
Architects: Biotechnology_Immunotherapy & Inflammation
Architects: Cancer & Oncology Companies
Architects: Gastroenterology_Gastrointestinal (to include Liver, Pancreas & metabolic dysfunction-associated steatotic liver disease (MASLD), Gout, MASH (Metabolic dysfunction-associated steatohepatitis), formerly, NASH (Non-Alcoholic SteatoHepatitis)Non-Alcoholic SteatoHepatitis (NASH)
Architects: Pulmonology (Drugs, Pharmaceuticals, Biotechnology & Biosimilars)
Industry: Denmark
Industry: San Diego, California
Porfolio Companies: Novo Nordisk
Watch List: Layoffs of 10% or More, Strategic Corporate Review, Delisting, Regulatory, Financial and/or Legal Issues
Children
Copenhagen, Denmark
Finance & Acquisitions: Galecto Biotech
Founded 2011
Key People: Galecto Biotech
Organization & Developments: Galecto Biotech
Jumps
Bristol-Myers Squibb Company (NYSE:BMY)
Novo Nordisk A/S (NYSE:NVO)